Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Graftskin skin replacement containing human dermis and epidermis with bovine collagen data

Results in 17 patients showed greater mean percent wound

Read the full 94 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE